BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30239102)

  • 1. Single-Step Per-O-Sulfonation of Sugar Oligomers with Concomitant 1,6-Anhydro Bridge Formation for Binding Fibroblast Growth Factors.
    Yeh CJ; Ku CC; Lin WC; Fan CY; Zulueta MML; Manabe Y; Fukase K; Li YK; Hung SC
    Chembiochem; 2019 Jan; 20(2):237-240. PubMed ID: 30239102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements.
    Zong C; Venot A; Li X; Lu W; Xiao W; Wilkes JL; Salanga CL; Handel TM; Wang L; Wolfert MA; Boons GJ
    J Am Chem Soc; 2017 Jul; 139(28):9534-9543. PubMed ID: 28651046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of heparan sulfate in fibroblast growth factor signalling: a structural view.
    Pellegrini L
    Curr Opin Struct Biol; 2001 Oct; 11(5):629-34. PubMed ID: 11785766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factors share binding sites in heparan sulphate.
    Kreuger J; Jemth P; Sanders-Lindberg E; Eliahu L; Ron D; Basilico C; Salmivirta M; Lindahl U
    Biochem J; 2005 Jul; 389(Pt 1):145-50. PubMed ID: 15769253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.
    Pye DA; Vivès RR; Hyde P; Gallagher JT
    Glycobiology; 2000 Nov; 10(11):1183-92. PubMed ID: 11087710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions that influence the binding of synthetic heparan sulfate based disaccharides to fibroblast growth factor-2.
    Li YC; Ho IH; Ku CC; Zhong YQ; Hu YP; Chen ZG; Chen CY; Lin WC; Zulueta MM; Hung SC; Lin MG; Wang CC; Hsiao CD
    ACS Chem Biol; 2014 Aug; 9(8):1712-7. PubMed ID: 24959968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of fibroblast growth factor.
    Gambarini AG; Miranda MT; Viviani W; Oyama Júnior S; Kiyota S; Toma IN
    Braz J Med Biol Res; 1996 Jul; 29(7):835-9. PubMed ID: 9070372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of fibroblast growth factor 1 binding heparan sulfate domain.
    Kreuger J; Prydz K; Pettersson RF; Lindahl U; Salmivirta M
    Glycobiology; 1999 Jul; 9(7):723-9. PubMed ID: 10362842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of synthetic heparan sulfate oligosaccharides with fibroblast growth factors and heparin-binding hemagglutinin.
    Zulueta MML; Chyan CL; Hung SC
    Curr Opin Struct Biol; 2018 Jun; 50():126-133. PubMed ID: 29554552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
    Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M
    Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction.
    Hu YP; Zhong YQ; Chen ZG; Chen CY; Shi Z; Zulueta MM; Ku CC; Lee PY; Wang CC; Hung SC
    J Am Chem Soc; 2012 Dec; 134(51):20722-7. PubMed ID: 23240683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of N-sulphated disaccharide units in heparin-like polysaccharides.
    Jacobsson I; Höök M; Pettersson I; Lindahl U; Larm O; Wirén E; von Figura K
    Biochem J; 1979 Apr; 179(1):77-87. PubMed ID: 157737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues.
    Friedl A; Chang Z; Tierney A; Rapraeger AC
    Am J Pathol; 1997 Apr; 150(4):1443-55. PubMed ID: 9094999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
    Harmer NJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of heparins with fibroblast growth factors: conformational aspects.
    Guerrini M; Hricovíni M; Torri G
    Curr Pharm Des; 2007; 13(20):2045-56. PubMed ID: 17627538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
    Olwin BB; Rapraeger A
    J Cell Biol; 1992 Aug; 118(3):631-9. PubMed ID: 1379245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a heparan sulfate mimetic disaccharide with a conformationally locked residue from a common intermediate.
    Fairweather JK; Karoli T; Liu L; Bytheway I; Ferro V
    Carbohydr Res; 2009 Nov; 344(17):2394-8. PubMed ID: 19819428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Function and structure of heparan sulfate-modification of FGF activities].
    Ishihara M
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(9):1122-33. PubMed ID: 7667499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.